Graphwear co-founders Saurabh Radhakrishnan and Rajatesh Gudibande want to make CGMs that use nanotechnology to measure blood glucose levels.
San Francisco-based Graphwear recently raised $20.5 million in funding led by venture capital firm Mayfield. It plans to use the funds to further develop its nanotech-based CGM device, grow its team and conduct more trials to prepare for a regulatory submission.
Clinical decision support systems have been with us since the 1980s. It’s time they delivered on their full promise.